Mum becomes first UK patient to trial 'gamechanger' MS treatment
Summary
A woman in the UK named Emily Henders is the first patient in the country to try a new treatment for multiple sclerosis (MS) as part of a global trial. This treatment, called CAR T-cell therapy, aims to reset the immune system to slow down or stop MS progression. The trial hopes to recruit more patients by 2027.Key Facts
- Emily Henders, a biology teacher from Hertfordshire, is involved in a clinical trial at University College London Hospital.
- The treatment Emily receives is called CAR T-cell therapy, originally used for treating blood cancer.
- Multiple sclerosis (MS) is an autoimmune disease where the body mistakenly attacks the nervous system.
- The therapy involves modifying T cells to target and remove certain immune cells that cause MS.
- Emily has been experiencing severe symptoms since her diagnosis in December 2021.
- The trial aims to recruit up to 18 patients globally by early 2027.
- There are 150,000 people in the UK with MS.
- If successful, CAR T-cell therapy might change how MS is treated.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.